Kidney Disease Market Report 2026
Download Free Sample Buy Now
Kidney Disease Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Kidney Disease Market Report 2026

Global Outlook – By Treatment (Medication, Dialysis, Surgery, Other Treatments), By Indication (Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indications), By Route Of Administration (Oral, Parenteral), By End-User (Hospitals, Diagnostic Laboratories, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Kidney Disease Market Overview

• Kidney Disease market size has reached to $114.39 billion in 2025

• Expected to grow to $159.58 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%

• Growth Driver: Surging Incidence Of Kidney Diseases Fuels Growth In The Kidney Disease Market

• Market Trend: Innovative Dialysis Solutions Supporting Patient-Centered Care

• North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Kidney Disease Market?

Kidney diseases refer to a group of conditions that affect the function and structure of the kidneys. The kidneys are vital organs responsible for filtering waste and excess fluids from the blood, regulating electrolyte balance, and producing hormones that control blood pressure and red blood cell production.

The main types of treatments for kidney disease are medication, dialysis, surgery, and others. Medication refers to the use of drugs or pharmaceutical substances to treat, manage, or prevent various medical conditions, such as health problems related to kidney diseases. The treatments are indicated for acute kidney injury, chronic kidney disease, end-stage renal disease, and others through oral and parenteral routes of administration. These are used by various end-users such as hospitals, diagnostic laboratories, and others.

Kidney Disease Market Global Report 2026 Market Report bar graph

What Is The Kidney Disease Market Size and Share 2026?

The kidney disease market size has grown strongly in recent years. It will grow from $114.39 billion in 2025 to $121.98 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to rising prevalence of chronic kidney disease, increasing incidence of diabetes and hypertension, established use of dialysis and medication therapies, growth in hospital-based renal care, expanding availability of diagnostic testing.

What Is The Kidney Disease Market Growth Forecast?

The kidney disease market size is expected to see strong growth in the next few years. It will grow to $159.58 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to aging global population with higher renal risk, increasing adoption of home-based dialysis, rising investment in kidney disease research, growing focus on early screening programs, expanding access to renal care in emerging markets. Major trends in the forecast period include rising focus on early detection and disease management, growing adoption of dialysis and renal replacement therapies, increasing demand for personalized kidney disease treatment, expansion of multidisciplinary care models for renal patients, improved patient awareness and preventive care initiatives.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Kidney Disease Market Segmentation

1) By Treatment: Medication, Dialysis, Surgery, Other Treatments

2) By Indication: Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indications

3) By Route Of Administration: Oral, Parenteral

4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Medication: Antihypertensives, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Vitamin D Analogs, Immunosuppressants

2) By Dialysis: Hemodialysis, Peritoneal Dialysis

3) By Surgery: Kidney Transplant, Nephrectomy, Renal Artery Bypass, Ureteral Surgery

4) By Other Treatments: Lifestyle And Dietary Modifications, Renal Replacement Therapy, Palliative Care

What Is The Driver Of The Kidney Disease Market?

The increased incidence of kidney diseases is expected to propel the growth of the kidney disease market going forward. Kidney diseases refer to a group of conditions that affect the function and structure of the kidneys. Kidney disorder medications are used to lower patients' blood pressure and reduce protein loss, slowing the progression of kidney damage, managing symptoms, and preventing complications. For instance, in June 2023, according to Kidney Research UK, a UK-based charitable organization that conducts research and advocacy efforts to improve understanding, prevention, and treatment of kidney diseases, an estimated 7.19 million people in the UK were affected by chronic kidney disease in 2023, representing more than 10% of the UK population and projected to increase to 7.61 million people by 2033. Therefore, the increased incidence of kidney diseases is driving the growth of the kidney disease industry.

Key Players In The Global Kidney Disease Market

Major companies operating in the kidney disease market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, AstraZeneca plc, Sanofi S.A., Bristol-Myers Squibb Company, AbbVie Inc., Bayer AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Astellas Pharma Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Kyowa Kirin Co. Ltd., Vertex Pharmaceuticals Inc., Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Lupin Limited, Aurobindo Pharma Limited

Global Kidney Disease Market Trends and Insights

Major companies operating in the kidney disease market are focusing on incorporating technology-driven innovations such as compact, cartridge-based hemodialysis systems to enhance treatment flexibility, patient usability, and workflow efficiency. Compact, cartridge-based hemodialysis systems are portable dialysis devices that use disposable dialysate cartridges instead of traditional bagged fluids, enabling capabilities such as automated dialysate preparation, simplified setup, and improved suitability for home-based therapy. For instance, in November 2024, Quanta Dialysis Technologies, a UK-based dialysis technology company, received FDA clearance for the Quanta Dialysis System, a cartridge-based hemodialysis system designed to support home hemodialysis and flexible care-setting deployment, featuring a compact footprint, on-demand dialysate generation, and an intuitive touchscreen interface. The quanta dialysis system improves patient autonomy, ease of treatment delivery, and operational efficiency across dialysis settings.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Kidney Disease Market?

In January 2023, AstraZeneca Pharmaceuticals LP, a US-based biopharmaceutical company, acquired CinCor Pharma Inc. for $1.8 billion. Through this acquisition, AstraZeneca intends to enhance its cardiorenal portfolio by incorporating CinCor's promising compound, baxdrostat (CIN-107). Baxdrostat is an aldosterone synthase inhibitor (ASI) specifically designed to lower blood pressure in patients with treatment-resistant hypertension, including those with chronic kidney disease. CinCor Pharma Inc. is a US-based clinical-stage biopharmaceutical company specializing in kidney disease medications and treatments.

Regional Outlook

North America was the largest region in the kidney disease market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Kidney Disease Market?

The kidney disease market consists of revenues earned by providing services such as hemodialysis, peritoneal dialysis, and kidney transplantation. The market value includes the value of related goods sold by the service provider or included within the service offering. The kidney disease also includes sales of drugs like galafold, sibnayal, tarpeyo, and cystadrops. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Kidney Disease Market Report 2026?

The kidney disease market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the kidney disease industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Kidney Disease Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $121.98 billion
Revenue Forecast In 2035 $159.58 billion
Growth Rate CAGR of 6.6% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Treatment, Indication, Route Of Administration, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, AstraZeneca plc, Sanofi S.A., Bristol-Myers Squibb Company, AbbVie Inc., Bayer AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Astellas Pharma Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Kyowa Kirin Co. Ltd., Vertex Pharmaceuticals Inc., Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Lupin Limited, Aurobindo Pharma Limited
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Kidney Disease Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Kidney Disease Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Kidney Disease Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Kidney Disease Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Biotechnology, Genomics & Precision Medicine

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Rising Focus On Early Detection And Disease Management

4.2.2 Growing Adoption Of Dialysis And Renal Replacement Therapies

4.2.3 Increasing Demand For Personalized Kidney Disease Treatment

4.2.4 Expansion Of Multidisciplinary Care Models For Renal Patients

4.2.5 Improved Patient Awareness And Preventive Care Initiatives

5. Kidney Disease Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Dialysis Centers

5.3 Nephrology Clinics

5.4 Diagnostic Laboratories

5.5 Ambulatory Care Centers

6. Kidney Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Kidney Disease Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Kidney Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Kidney Disease Market Size, Comparisons And Growth Rate Analysis

7.3. Global Kidney Disease Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Kidney Disease Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Kidney Disease Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Kidney Disease Market Segmentation

9.1. Global Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Medication, Dialysis, Surgery, Other Treatments

9.2. Global Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indications

9.3. Global Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Parenteral

9.4. Global Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Diagnostic Laboratories, Other End-Users

9.5. Global Kidney Disease Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antihypertensives, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Vitamin D Analogs, Immunosuppressants

9.6. Global Kidney Disease Market, Sub-Segmentation Of Dialysis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hemodialysis, Peritoneal Dialysis

9.7. Global Kidney Disease Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Kidney Transplant, Nephrectomy, Renal Artery Bypass, Ureteral Surgery

9.8. Global Kidney Disease Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lifestyle And Dietary Modifications, Renal Replacement Therapy, Palliative Care

10. Kidney Disease Market Regional And Country Analysis

10.1. Global Kidney Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Kidney Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Kidney Disease Market

11.1. Asia-Pacific Kidney Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Kidney Disease Market

12.1. China Kidney Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Kidney Disease Market

13.1. India Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Kidney Disease Market

14.1. Japan Kidney Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Kidney Disease Market

15.1. Australia Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Kidney Disease Market

16.1. Indonesia Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Kidney Disease Market

17.1. South Korea Kidney Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Kidney Disease Market

18.1. Taiwan Kidney Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Kidney Disease Market

19.1. South East Asia Kidney Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Kidney Disease Market

20.1. Western Europe Kidney Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Kidney Disease Market

21.1. UK Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Kidney Disease Market

22.1. Germany Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Kidney Disease Market

23.1. France Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Kidney Disease Market

24.1. Italy Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Kidney Disease Market

25.1. Spain Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Kidney Disease Market

26.1. Eastern Europe Kidney Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Kidney Disease Market

27.1. Russia Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Kidney Disease Market

28.1. North America Kidney Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Kidney Disease Market

29.1. USA Kidney Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Kidney Disease Market

30.1. Canada Kidney Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Kidney Disease Market

31.1. South America Kidney Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Kidney Disease Market

32.1. Brazil Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Kidney Disease Market

33.1. Middle East Kidney Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Kidney Disease Market

34.1. Africa Kidney Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Kidney Disease Market, Segmentation By Treatment, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Kidney Disease Market Regulatory and Investment Landscape

36. Kidney Disease Market Competitive Landscape And Company Profiles

36.1. Kidney Disease Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Kidney Disease Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Kidney Disease Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

37. Kidney Disease Market Other Major And Innovative Companies

Sanofi S.A., Bristol-Myers Squibb Company, AbbVie Inc., Bayer AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Astellas Pharma Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Kyowa Kirin Co. Ltd., Vertex Pharmaceuticals Inc., Gilead Sciences Inc.

38. Global Kidney Disease Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Kidney Disease Market

40. Kidney Disease Market High Potential Countries, Segments and Strategies

40.1 Kidney Disease Market In 2030 - Countries Offering Most New Opportunities

40.2 Kidney Disease Market In 2030 - Segments Offering Most New Opportunities

40.3 Kidney Disease Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Kidney Disease Market, Overview Of Key Products - Product Examples
  • Table 2: Global Kidney Disease Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Kidney Disease Market, Supply Chain Analysis
  • Table 4: Global Kidney Disease Market, Major Raw Material Providers
  • Table 5: Global Kidney Disease Market, Major Resource Providers
  • Table 6: Global Kidney Disease Market, Major Manufacturers (Suppliers)
  • Table 7: Global Kidney Disease Market, Major Distributors And Channel Partners
  • Table 8: Global Kidney Disease Market, Key Technologies & Future Trends
  • Table 9: Global Kidney Disease Market, Major Trends
  • Table 10: Global Kidney Disease Market, Major End Users
  • Table 11: Global Kidney Disease Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Kidney Disease Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Kidney Disease Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Kidney Disease Market - TAM, US$ Billion, 2025
  • Table 15: Global Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Kidney Disease Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Kidney Disease Market, Sub-Segmentation Of Dialysis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Kidney Disease Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Kidney Disease Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Kidney Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Kidney Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Kidney Disease Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Kidney Disease Market - Company Scoring Matrix
  • Table 99: Pfizer Inc. Financial Performance
  • Table 100: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 101: Merck & Co. Inc. Financial Performance
  • Table 102: Novartis AG Financial Performance
  • Table 103: AstraZeneca plc Financial Performance
  • Table 104: Global Kidney Disease Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Kidney Disease Market, Competitive Dashboard
  • Table 106: Global Kidney Disease Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Kidney Disease Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Table 108: Global, Kidney Disease Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 109: Global, Kidney Disease Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

    Figure 1: Global Kidney Disease Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Kidney Disease Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Kidney Disease Market, Supply Chain Analysis
  • Figure 4: Global Kidney Disease Market, Major Raw Material Providers
  • Figure 5: Global Kidney Disease Market, Major Resource Providers
  • Figure 6: Global Kidney Disease Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Kidney Disease Market, Major Distributors And Channel Partners
  • Figure 8: Global Kidney Disease Market, Key Technologies & Future Trends
  • Figure 9: Global Kidney Disease Market, Major Trends
  • Figure 10: Global Kidney Disease Market, Major End Users
  • Figure 11: Global Kidney Disease Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Kidney Disease Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Kidney Disease Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Kidney Disease Market - TAM, US$ Billion, 2025
  • Figure 15: Global Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Kidney Disease Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Kidney Disease Market, Sub-Segmentation Of Dialysis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Kidney Disease Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Kidney Disease Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Kidney Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Kidney Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Kidney Disease Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Kidney Disease Market - Company Scoring Matrix
  • Figure 99: Pfizer Inc. Financial Performance
  • Figure 100: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 101: Merck & Co. Inc. Financial Performance
  • Figure 102: Novartis AG Financial Performance
  • Figure 103: AstraZeneca plc Financial Performance
  • Figure 104: Global Kidney Disease Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Kidney Disease Market, Competitive Dashboard
  • Figure 106: Global Kidney Disease Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Kidney Disease Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Figure 108: Global, Kidney Disease Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 109: Global, Kidney Disease Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Coxsackievirus Infections Treatment Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Read More About Coxsackievirus Infections Treatment Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Cranial Fixation System Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

Read More About Cranial Fixation System Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

Crow's Feet Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

Read More About Crow's Feet Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

Cutaneous Squamous Cell Carcinoma (cSCC) Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Cutaneous Squamous Cell Carcinoma (cSCC) Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Kidney Disease Market Report 2026 - Global Outlook – By Treatment (Medication, Dialysis, Surgery, Other Treatments), By Indication (Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indications)...

Chronic Kidney Disease Market Report 2026 - Global Outlook – By Diagnosis (Blood Test, Urine Test, Imaging Test, Kidney Biopsy), By Treatment (Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatme...

Diabetic Kidney Disease Market Report 2026 - Global Outlook – By Type (Type 1 Diabetes, Type 2 Diabetes), By Treatment (Angiotensin Receptor Blockers (Arbs), Angiotensin-Converting Enzyme (Ace) Inhibitors, Antioxidant In...

Rare Kidney Diseases Market Report 2026 - Global Outlook – By Target Indication (IgA Nephropathy, Lupus Nephritis, Focal Segmental Glomerular Sclerosis, Membranous Nephropathy, C3 Glomerulopathy, Other Target Indications...

Kidney Dialysis Market Report 2026 - Global Outlook – By Type (Hemodialysis, Peritoneal Dialysis), By Product And Service (Equipment, Consumables, Dialysis Drugs, Services), By End-User (Home Care, Dialysis Centers And H...

Veterinary Renal Disease Market Report 2026 - Global Outlook – By Type (Diagnosis, Treatment), By Animal Type (Canine, Feline, Bovine, Equine, Other Animal Types), By Indication (Renal Failure, Chronic Kidney Disease (Ck...

Kidney Biopsy Market Report 2026 - Global Outlook – By Type (Percutaneous Biopsy, Surgical Biopsy), By Indication (Kidney Failure, Kidney Transplant, Hematuria, Proteinuria), By End-User (Hospitals And Clinics, Tertiary ...

Kidney Transplant Market Report 2026 - Global Outlook – By Transplant Type (Deceased-Donor Kidney Transplant, Living-Donor Kidney Transplant, Expanded Criteria Donor), By Age Group (Adult, Pediatrics), By End-User (Trans...

Frequently Asked Questions

The Kidney Disease market was valued at $114.39 billion in 2025, increased to $121.98 billion in 2026, and is projected to reach $159.58 billion by 2030. request a sample here

The global Kidney Disease market is expected to grow at a CAGR of 6.9% from 2026 to 2035 to reach $159.58 billion by 2035. request a sample here

Some Key Players in the Kidney Disease market Include, Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, AstraZeneca plc, Sanofi S.A., Bristol-Myers Squibb Company, AbbVie Inc., Bayer AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Astellas Pharma Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Kyowa Kirin Co. Ltd., Vertex Pharmaceuticals Inc., Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Lupin Limited, Aurobindo Pharma Limited . request a sample here

Major trend in this market includes: Innovative Dialysis Solutions Supporting Patient-Centered Care. For further insights on this market. request a sample here

North America was the largest region in the kidney disease market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Major companies operating in the Kidney Disease Market Report 2026 market are Major companies operating in the kidney disease market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, AstraZeneca plc, Sanofi S.A., Bristol-Myers Squibb Company, AbbVie Inc., Bayer AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Astellas Pharma Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Kyowa Kirin Co. Ltd., Vertex Pharmaceuticals Inc., Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Lupin Limited, Aurobindo Pharma Limited request a sample here.

North America was the largest region in the kidney disease market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us